Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03206047
Title Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

peritoneal carcinoma

fallopian tube carcinoma

ovary epithelial cancer

Therapies

Atezolizumab + Guadecitabine

Atezolizumab

Atezolizumab + Guadecitabine + Rasdegafusp alfa

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.